來源:[1] 獨家:美國FDA高層內部推動加快禮來減肥藥裁決 - 路透社 (https://www.reuters.com/sustainability/boards ...)[2] FDA官僚機構的缺失正在自毀藥企前景 - BioSpace (https://www.biospace.com/policy/absence-of-bu ...)[3] FDA批准USAntibiotics’ Augmentin XR,開創快速審查項目先河 - BioSpace (https://www.biospace.com/press-releases/fda-a ...)